Northwestern Mutual Wealth Management
ESPR

Northwestern Mutual Wealth Management’s Esperion Therapeutics ESPR Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,000
Closed -$1.39K – 3353
2023
Q2 		$1.39K Buy
+1,000
New +$1.4K ﹤0.01% 3046
2019
Q1 		– Sell
-22
Closed -$1K – 2577
2018
Q4 		$1K Buy
+22
New +$1.06K ﹤0.01% 2273
2016
Q4 		– Sell
-16
Closed – – 2403
2016
Q3 		$0 Buy
+16
New +$181 ﹤0.01% 2216
2015
Q4 		– Sell
-100
Closed -$2K – 1661
2015
Q3 		$2K Buy
+100
New +$6.28K ﹤0.01% 1434

Other funds holding ESPR

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northwestern Mutual Wealth Management's ESPR Position: Q3 2023 in Review

Northwestern Mutual Wealth Management sold out of Esperion Therapeutics (ESPR) in Q3 2023, closing a stake of 1,000 shares — an estimated $1.39K sold.

Northwestern Mutual Wealth Management first reported a position in ESPR in Q3 2015 and held it in 4 quarters. The position peaked at $2K in Q3 2015. 122 funds tracked by Wall St. Rank hold ESPR as of Q3 2023.

  • Northwestern Mutual Wealth Management reported no remaining Esperion Therapeutics position as of Q3 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 1,000 Esperion Therapeutics shares in Q3 2023, an estimated $1.39K.
  • Northwestern Mutual Wealth Management first reported a position in Esperion Therapeutics in Q3 2015 and held it in 4 quarters.
  • Northwestern Mutual Wealth Management's Esperion Therapeutics position peaked at $2K in Q3 2015.
  • 122 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2023, filed 14 Nov 2023.